tiprankstipranks
Shenguan Holdings (Group) Limited (HK:0829)
:0829
Hong Kong Market
Want to see HK:0829 full AI Analyst Report?

Shenguan Holdings (Group) Limited (0829) AI Stock Analysis

0 Followers

Top Page

HK:0829

Shenguan Holdings (Group) Limited

(0829)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
HK$0.17
▼(-41.07% Downside)
Action:Reiterated
Date:05/14/26
The score is held down primarily by deteriorating financial performance (shift to a net loss, compressed margins, and two years of negative operating/free cash flow). Technical indicators also point to a sustained downtrend, despite oversold readings. The key offsets are a relatively conservative balance sheet and an unusually high dividend yield, though sustainability risk remains given weak cash generation.
Positive Factors
Niche market position
Shenguan occupies a specialized niche as a dedicated edible collagen casing supplier to meat processors in China. That specialization creates durable customer relationships, repeat order patterns, and technical barriers to entry versus generalist food suppliers, supporting stable long-term demand.
Negative Factors
Profitability deterioration
Sharp margin compression across gross, EBITDA and EBIT reduced the company's ability to self-fund operations. Sustained losses undermine retained earnings and investor confidence, impairing capacity to reinvest in production or marketing needed to regain market share over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Niche market position
Shenguan occupies a specialized niche as a dedicated edible collagen casing supplier to meat processors in China. That specialization creates durable customer relationships, repeat order patterns, and technical barriers to entry versus generalist food suppliers, supporting stable long-term demand.
Read all positive factors

Shenguan Holdings (Group) Limited (0829) vs. iShares MSCI Hong Kong ETF (EWH)

Shenguan Holdings (Group) Limited Business Overview & Revenue Model

Company Description
Shenguan Holdings (Group) Limited, an investment holding company, manufactures and sells edible collagen sausage casing products in Mainland China, rest of Asia, and internationally. It also manufactures pharmaceutical products and intermediates, ...
How the Company Makes Money
The company makes money primarily by manufacturing and selling edible collagen casings to meat product manufacturers and other food processors. Revenue is mainly generated from (1) product sales of collagen casings—typically sold by specification ...

Shenguan Holdings (Group) Limited Financial Statement Overview

Summary
Overall fundamentals have weakened: profitability deteriorated from a small profit in 2024 to a net loss in 2025 with sharp gross/EBITDA margin compression, and operating/free cash flow were negative in both 2024 and 2025. The main support is a still-conservative balance sheet with low-to-moderate leverage, providing some financial flexibility despite negative ROE in 2025.
Income Statement
35
Negative
Balance Sheet
68
Positive
Cash Flow
24
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.02B1.02B1.11B1.03B1.17B
Gross Profit104.73M171.08M170.86M160.47M310.49M
EBITDA14.68M90.44M178.00M79.11M211.95M
Net Income-69.77M26.66M31.24M23.57M122.65M
Balance Sheet
Total Assets2.77B2.83B2.96B3.35B3.31B
Cash, Cash Equivalents and Short-Term Investments555.58M503.80M824.01M953.95M998.90M
Total Debt406.03M247.97M277.37M540.73M427.95M
Total Liabilities638.58M536.49M581.08M834.97M656.48M
Stockholders Equity2.13B2.30B2.38B2.52B2.66B
Cash Flow
Free Cash Flow-126.23M-234.02M93.98M34.24M110.55M
Operating Cash Flow-92.68M-143.25M176.45M106.04M179.71M
Investing Cash Flow72.68M161.69M298.11M44.80M-212.22M
Financing Cash Flow36.61M-161.84M-455.19M-71.04M104.16M

Shenguan Holdings (Group) Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.28
Price Trends
50DMA
0.20
Negative
100DMA
0.23
Negative
200DMA
0.26
Negative
Market Momentum
MACD
-0.01
Positive
RSI
22.52
Positive
STOCH
31.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0829, the sentiment is Negative. The current price of 0.28 is above the 20-day moving average (MA) of 0.18, above the 50-day MA of 0.20, and above the 200-day MA of 0.26, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 22.52 is Positive, neither overbought nor oversold. The STOCH value of 31.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0829.

Shenguan Holdings (Group) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$1.19B7.695.61%10.44%-1.52%6.08%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
56
Neutral
HK$1.01B5.214.38%5.38%-11.88%-61.92%
48
Neutral
HK$747.55M-395.340.81%0.00%-8.65%-112.54%
46
Neutral
HK$510.42M-10.82-3.25%15.38%0.78%-360.00%
44
Neutral
HK$1.07B10.83-11.47%13.86%-83.41%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0829
Shenguan Holdings (Group) Limited
0.16
-0.11
-40.82%
HK:1583
Qinqin Foodstuffs Group (Cayman) Company
0.99
-0.15
-13.16%
HK:2317
Vedan International (Holdings) Ltd.
0.78
0.22
39.29%
HK:3838
China Starch Holdings Limited
0.17
<0.01
1.20%
HK:0809
Global Bio-chem Technology Group Co. Ltd.
0.06
>-0.01
-13.51%

Shenguan Holdings (Group) Limited Corporate Events

Shenguan Sets 2026 AGM to Renew Auditor, Board Seats and Share Issuance Mandate
Apr 29, 2026
Shenguan Holdings (Group) Limited has called its annual general meeting for 5 June 2026 in Hong Kong to present the audited consolidated accounts for the year ended 31 December 2025, re-appoint Ernst Young as auditors, and re-elect two executive ...
Shenguan Chairwoman Boosts Majority Stake with On-Market Share Purchases
Apr 15, 2026
Shenguan Holdings (Group) Limited has disclosed that Shenguan Biology Science Technology Investment Company Limited, a vehicle ultimately controlled by Chairwoman and executive director Zhou Yaxian, acquired 8,452,000 shares of the company on the...
Shenguan Swings to 2025 Loss Despite Stable Revenue and Rising Cost Pressures
Mar 30, 2026
Shenguan Holdings reported largely flat revenue of RMB1.02 billion for 2025, but swung from a profit to a net loss attributable to shareholders of RMB69.8 million as gross profit fell and cost of sales rose. The company also recorded net cash outf...
Shenguan Holdings Proposes Major Update to Articles to Support Paperless, Uncertificated Regime
Mar 30, 2026
Shenguan Holdings (Group) Limited plans to overhaul its existing articles of association to align with the latest Hong Kong listing requirements and modern market infrastructure. The proposed changes focus on accommodating the expanded paperless l...
Shenguan Sets March 2026 Board Meeting to Approve 2025 Results and Consider Final Dividend
Mar 18, 2026
Shenguan Holdings (Group) Limited has scheduled a board meeting for 30 March 2026 to review and approve the group&#8217;s annual results for the year ended 31 December 2025 and to authorise their publication. The board will also consider the payme...
Shenguan Issues Profit Warning as Trial Production and Tax Charges Drive Projected 2025 Loss
Mar 16, 2026
Shenguan Holdings (Group) Limited has warned that it expects to swing to a net loss attributable to shareholders of between RMB65 million and RMB78 million for the year ended 31 December 2025, compared with a profit of around RMB26.7 million a yea...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 14, 2026